Skip to main content
Loading

Assessing clinical trial designs in advancing novel immunotherapeutic drugs

25 Sep 2025
Clinical Development
  • Evaluating adaptive trial designs to accelerate immunotherapy development
  • Balancing safety and efficacy endpoints in early-phase trials
  • Integrating biomarkers for patient stratification and response prediction
  • Addressing challenges in translating preclinical success to clinical outcomes
Industry Expert
Venita DeAlmeida, Clinical Science Lead - 3T Biosciences